P-STAT3 Expression in Breast Cancer: Clinical Correlations and Limitations as a Prognostic Marker
Journal of Breast Disease · 30.06.2026 · 14 (1) · 1-8
DOI: 10.14449/jbd.2026.14.1.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Breast Disease, online erschienen am 30.06.2026. Verfasst von Hwiyeong Jin und 7 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Gefördert von: Korea Institute of Radiological and Medical Sciences, Ministry of Science and ICT.
Abstract (Originalsprache)
Purpose
Phosphorylated signal transducer and activator of transcription 3 (p-STAT3) plays a critical role in tumor growth, survival, and immune evasion. Elevated p-STAT3 expression has been reported in breast cancer; however, its prognostic and predictive significance remains controversial. In this study, we aimed to investigate the clinical implications of p-STAT3 expression in breast cancer.
Methods
This retrospective cohort study included 924 patients with invasive breast cancer, excluding 15 patients with de novo stage IV disease. Disease-free survival (DFS) and late recurrence-free survival were analyzed. In addition, dynamic changes in p-STAT3 levels were quantitatively calculated preand post-neoadjuvant chemotherapy and at recurrence, when available.
Results
Kaplan–Meier analysis revealed no significant difference in DFS between the p-STAT3-positive and -negative groups (p=0.875). Subgroup analysis showed that patients with p-STAT3-positive triple-negative breast cancer exhibited a numerically lower late recurrence-free survival, although this did not reach statistical significance (p=0.149). Conversely, in patients receiving neoadjuvant chemotherapy, p-STAT3 expression significantly decreased following treatment (p
Förderung
- Korea Institute of Radiological and Medical Sciences
- Ministry of Science and ICT
Zitieren
APA
Jin, H., Kim, H., Sung, M., Park, C., Kong, J., Lim, D., Lim, H., & Han, Y. (2026). P-STAT3 Expression in Breast Cancer: Clinical Correlations and Limitations as a Prognostic Marker. Journal of Breast Disease, 14(1), 1-8. https://doi.org/10.14449/jbd.2026.14.1.1
Vancouver
Jin H, Kim H, Sung M, Park C, Kong J, Lim D, et al. P-STAT3 Expression in Breast Cancer: Clinical Correlations and Limitations as a Prognostic Marker. Journal of Breast Disease. 2026;14(1):1-8. doi:10.14449/jbd.2026.14.1.1
BibTeX
@article{Jin2026,
author = {Jin, Hwiyeong and Kim, Hyun-Ah and Sung, Minki and Park, Chansup and Kong, Joonseog and Lim, Donghyun and Lim, Hanseul and Han, Yireh},
title = {P-STAT3 Expression in Breast Cancer: Clinical Correlations and Limitations as a Prognostic Marker},
journal = {Journal of Breast Disease},
year = {2026},
volume = {14},
number = {1},
pages = {1--8},
doi = {10.14449/jbd.2026.14.1.1}
}
EUVIMED